Bleeding characteristics of patients with congenital hemophilia and inhibitors: Data from a postmarketing study of recombinant activated factor VII (SMART-7)

被引：0
|
作者：
Demartis, Francesco [1 ]
Benson, Gary [2 ]
Batorova, Angelika [3 ]
Cepo, Katarina [4 ]
Zak, Marek [4 ]
Chambost, Herve [5 ]
机构：
[1] Azienda Osped Univ Careggi, Haemophilia Ctr, Florence, Italy
[2] Belfast City Hosp, Northern Ireland Haemophilia Ctr, Belfast, Antrim, North Ireland
[3] Comenius Univ, Fac Med, Univ Hosp, Bratislava, Slovakia
[4] Novo Nordisk AS, Soborg, Denmark
[5] Hop Enfants La Timone, Marseille Univ Hosp, Pediat Hematol Unit, Marseille, France
来源：
HAEMOPHILIA | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：68 / 68
页数：1
相关论文
共 50 条
  • [31] Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleeding
    Klitgaard, Thomas
    Palacios, Rene Tabanera y
    Boffard, Kenneth D.
    Lau, Philip T. C.
    Warren, Brian
    Rizoli, Sandro
    Rossaint, Rolf
    Kluger, Yoram
    Riou, Bruno
    CRITICAL CARE, 2006, 10 (04):
  • [32] Recombinant activated factor VII for non-hemophiliac bleeding patients
    Uhlmann, EJ
    Eby, CS
    CURRENT OPINION IN HEMATOLOGY, 2004, 11 (03) : 198 - 204
  • [33] Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleeding
    Thomas Klitgaard
    Rene Tabanera y Palacios
    Kenneth D Boffard
    Philip TC Iau
    Brian Warren
    Sandro Rizoli
    Rolf Rossaint
    Yoram Kluger
    Bruno Riou
    Critical Care, 10
  • [34] Use of recombinant activated factor VII for surgical interventions in patients with inhibitor hemophilia
    Polyanskaya, T. Yu.
    Zorenko, V. Yu.
    Karpov, E. E.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2008, 53 (03): : 3 - 5
  • [35] The Comparison of Hemostatic Effects of Recombinant Activated Factor VII (rFVIIa) in Thrombocytopenic Patients (pts) and Hemophilia Pts with Inhibitors
    Galstian, Gennadii M.
    Kolosova, Irina V.
    Gemdzhian, Eduard
    Zorenko, Vladimir Yu.
    Polyanskaya, Tatyana A.
    Orel, Elena B.
    Savchenko, Valeri G.
    BLOOD, 2015, 126 (23)
  • [36] Treatment of acute bleeding in acquired haemophilia A with recombinant activated factor VII: analysis of 10-year Japanese postmarketing surveillance data
    Amano, K.
    Seita, I.
    Higasa, S.
    Sawada, A.
    Kuwahara, M.
    Shima, M.
    HAEMOPHILIA, 2017, 23 (01) : 50 - 58
  • [37] Results of the WIRK prospective, non-interventional observational study of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors and other bleeding disorders
    Birschmann, I.
    Klamroth, R.
    Eichler, H.
    Schenk, J.
    Kirchmaier, C. M.
    Halimeh, S.
    HAEMOPHILIA, 2013, 19 (05) : 679 - 685
  • [38] A Comparison Between Recombinant Activated Factor VII (Aryoseven) and Novoseven in Patients With Congenital Factor VII Deficiency
    Faranoush, M.
    Abolghasemi, Hassan
    Toogeh, Gh.
    Karimi, M.
    Eshghi, P.
    Managhchi, M.
    Hoorfar, H.
    Dehdezi, B. Keikhaei
    Mehrvar, A.
    Khoeiny, B.
    Kamyar, K.
    Heshmat, R.
    Baghaeipour, M. R.
    Mirbehbahani, N. B.
    Fayazfar, R.
    Ahmadinejad, M.
    Naderi, M.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2015, 21 (08) : 724 - 728
  • [39] Use of recombinant activated factor VII in patients with severe coagulopathy and bleeding - In Reply
    Svartholm, E
    Annerhagen, V
    Lanne, T
    ANESTHESIOLOGY, 2003, 98 (04) : 1027 - 1027
  • [40] Recombinant activated factor VII in controlling bleeding in non-hemophiliac patients
    AlGahtani, Farjah H.
    Alshaikh, Mashael
    AlDiab, AbdulRehman
    ANNALS OF SAUDI MEDICINE, 2010, 30 (03) : 198 - 202
12345